Compare PWCM & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PWCM | BDRX |
|---|---|---|
| Founded | N/A | 2000 |
| Country | United States | United Kingdom |
| Employees | 19 | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0M | 1.6M |
| IPO Year | 2015 | 2015 |
| Metric | PWCM | BDRX |
|---|---|---|
| Price | $1.16 | $0.79 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 457.5K | 243.7K |
| Earning Date | N/A | 09-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 34.66 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $8,844,733.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.02 | $0.60 |
| 52 Week High | $2.27 | $11.88 |
| Indicator | PWCM | BDRX |
|---|---|---|
| Relative Strength Index (RSI) | 39.75 | 19.48 |
| Support Level | $1.08 | $0.60 |
| Resistance Level | $1.57 | $1.50 |
| Average True Range (ATR) | 0.20 | 0.14 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 22.40 | 4.41 |
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.